iamYiam Company

iamYiam provides a saliva-based DNA testing kit which tests for forty parameters and enables the company to understand how customers process nutrients, respond to certain activities, any pre-disposition to diabetes or slow metabolism. The iamYiam algorithms then match the user to therapists and a personalised nutritional plan. The company also applies machine learning to analyzing the patient data they collect to improve the matching algorithms and better predict effective healthcare plans.
Technology:
Nutrition/Nutraceuticals
Industry:
P4 Medicine
Headquarters:
Europe
Founded Date:
1905-07-09
Investors Number:
1
Total Funding:
â¬550K
Last Funding Type:
Seed
Register and Claim Ownership